Table 5.

Multivariate analysis for CMR predictors of Major Adverse Cardiac Events

Variables	Presence of MACE at FU (N = 22)	Absence of MACE at FU (N = 181)	P value	HR (95 % CI)
Presence and extent of Early Gadolinium Enhancement (% myocardial surface area)	2.2 % ± 4.1	5.1 % ± 6.0	P = 0.322	0.93 (0.80–1.07)
Age	47 ± 13	42 ± 17	P = 0.847	0.85 (0.96–1.03)
Myocardial extent of hyper T2 signal (% myocardial surface area)	4.9 % ± 4.9	7.0 % ± 7.0	P = 0.601	0.97 (0.86–1.08)
Initial LVEF, %	51.9 ± 9.0	57.6 ± 8.9	P = 0.04	0.89 (0.80–0.98)